BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
359 results:

  • 1. Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression.
    Mondal DK; Xie C; Pascal GJ; Buraschi S; Iozzo RV
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2317760121. PubMed ID: 38652741
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Wireless electrostimulation for cancer treatment: An integrated nanoparticle/coaxial fiber mesh platform.
    Resina L; Garrudo FFF; Alemán C; Esteves T; Ferreira FC
    Biomater Adv; 2024 Jun; 160():213830. PubMed ID: 38552500
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nanographene-Au fine-tuning to intensify plasmonic-resonance of polymeric hybrid bionanosystem for synergistic phototherapy and nerve photobiomodulation.
    Jaswal R; Kumar D; Rezk AI; Kaliannagounder VK; Park CH; Min KH
    Colloids Surf B Biointerfaces; 2024 May; 237():113820. PubMed ID: 38502975
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021-2023).
    Zeng J; Deng Q; Chen Z; Yan S; Dong Q; Zhang Y; Cui Y; Li L; He Y; Shi J
    Bioorg Chem; 2024 May; 146():107278. PubMed ID: 38484586
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Deguelin and Paclitaxel Loaded PEG-pcl Nano-Micelles for Suppressing the Proliferation and Inducing Apoptosis of breast cancer Cells.
    Wang Y; Lan Y; Wu L; Zhang S; Su Q; Yang Q
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):90. PubMed ID: 38420791
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeted pH- and redox-responsive AuS/micelles with low CMC for highly efficient sonodynamic therapy of metastatic breast cancer.
    Maghsoudian S; Motasadizadeh H; Farhadnejad H; Fatahi Y; Fathian Nasab MH; Mahdieh A; Nouri Z; Abdollahi A; Amini M; Atyabi F; Dinarvand R
    Biomater Adv; 2024 Apr; 158():213771. PubMed ID: 38271801
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Folate receptor-mediated delivery system based on chitosan coated polymeric nanoparticles for combination therapy of breast cancer.
    Jamali S; Jamali B; Abedi F; Firoozrai M; Davaran S; Vaghefi Moghaddam S
    J Biomater Sci Polym Ed; 2024 Apr; 35(5):605-627. PubMed ID: 38271010
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle.
    Da M; Li S; Yang R; Jia Z; Ma Y; Qi F; Zhao J; Shen G; Chen D
    Nanotechnology; 2023 Dec; 35(11):. PubMed ID: 38081078
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells.
    Banerjee K; Kerzel T; Bekkhus T; de Souza Ferreira S; Wallmann T; Wallerius M; Landwehr LS; Agardy DA; Schauer N; Malmerfeldt A; Bergh J; Bartish M; Hartman J; Östman A; Squadrito ML; Rolny C
    Cell Rep; 2023 Dec; 42(12):113507. PubMed ID: 38041815
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Adjuvant Auger Electron-Emitting Radioimmunotherapy with [
    Facca VJ; Cai Z; Ku A; Georgiou CJ; Reilly RM
    Mol Pharm; 2023 Dec; 20(12):6407-6419. PubMed ID: 37983089
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Improved antitumor activity through a tyramidyl maslinic acid derivative. Design and validation as drug-loaded electrospun polymeric nanofibers.
    Luque C; de la Cabeza Fernández M; Fuentes-Rios D; Cepero A; Contreras-Cáceres R; Doña M; Perazzoli G; Lozano-Chamizo L; Filice M; Marciello M; Gonzalez-Rumayor V; López-Romero JM; Cabeza L; Melguizo C; Prados J
    Eur J Pharm Biopharm; 2023 Dec; 193():241-253. PubMed ID: 37972906
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A facile, flexible, and multifunctional thermo-chemotherapy system for customized treatment of drug-resistant breast cancer.
    Chen L; Nabil A; Fujisawa N; Oe E; Li K; Ebara M
    J Control Release; 2023 Nov; 363():550-561. PubMed ID: 37804880
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive breast cancer and Beyond.
    Wu J; Subbiah V
    Cancer Res; 2023 Oct; 83(19):3159-3161. PubMed ID: 37779428
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes.
    Jing Z; Li Y; Song J; Zang X
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126912. PubMed ID: 37722648
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeted drug-loaded PLGA-pcl microspheres for specific and localized treatment of triple negative breast cancer.
    Nwazojie CC; Obayemi JD; Salifu AA; Borbor-Sawyer SM; Uzonwanne VO; Onyekanne CE; Akpan UM; Onwudiwe KC; Oparah JC; Odusanya OS; Soboyejo WO
    J Mater Sci Mater Med; 2023 Aug; 34(8):41. PubMed ID: 37530973
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03).
    Kobayashi K; Masuda N; Mizuno T; Miura K; Tokuda Y; Yoshinami T; Kawaguchi H; Ohtani S; Saeki T; Toi M; Takeuchi M; Ito Y
    Breast Cancer Res Treat; 2023 Oct; 201(3):409-415. PubMed ID: 37480384
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Enzyme/pH dual stimuli-responsive nanoplatform co-deliver disulfiram and doxorubicin for effective treatment of breast cancer lung metastasis.
    Xiao P; Tao X; Wang H; Liu H; Feng Y; Zhu Y; Jiang Z; Yin T; Zhang Y; He H; Gou J; Tang X
    Expert Opin Drug Deliv; 2023; 20(7):1015-1031. PubMed ID: 37452715
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
    Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
    J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Eta polycaprolactone (ε-pcl) implants appear to cause a partial differentiation of breast cancer lung metastasis in a murine model.
    Benzon B; Marijan S; Pervan M; Čikeš Čulić V
    BMC Cancer; 2023 Apr; 23(1):343. PubMed ID: 37055783
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. breast Tissue Reconstruction Using Polycaprolactone Ball Scaffolds in a Partial Mastectomy Pig Model.
    Shim KS; Ryu DH; Jo HS; Kim KB; Kim DH; Park YK; Heo M; Cho HE; Yoon ES; Lee WJ; Roh TS; Song SY; Baek W
    Tissue Eng Regen Med; 2023 Jul; 20(4):607-619. PubMed ID: 37017922
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.